These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21502277)

  • 1. Indian generic drug production. Benefits of EU-India free trade agreement.
    Ager B
    BMJ; 2011 Apr; 342():d2439. PubMed ID: 21502277
    [No Abstract]   [Full Text] [Related]  

  • 2. The production of generic drugs in India.
    Love J
    BMJ; 2011 Mar; 342():d1694. PubMed ID: 21427048
    [No Abstract]   [Full Text] [Related]  

  • 3. India-EU free trade agreement threatens access to generic drugs, MSF warns.
    Moszynski P
    BMJ; 2010 Apr; 340():c2309. PubMed ID: 20423974
    [No Abstract]   [Full Text] [Related]  

  • 4. . . . and Brazilian AIDS programme threatened by US trade action.
    Int J Epidemiol; 2001 Apr; 30(2):413. PubMed ID: 11369751
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 6. Restrictions on generic drugs "infringe the right to health".
    Moszynski P
    BMJ; 2010 Dec; 341():c7246. PubMed ID: 21163838
    [No Abstract]   [Full Text] [Related]  

  • 7. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
    Moszynski P
    BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
    [No Abstract]   [Full Text] [Related]  

  • 8. Brazil and India file complaint against EU over seizure of generic drugs.
    Zarocostas J
    BMJ; 2010 May; 340():c2672. PubMed ID: 20483945
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes to India's patent law may deny cheap drugs to millions.
    Mudur G
    BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
    [No Abstract]   [Full Text] [Related]  

  • 10. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
    Rosina MS; Shaver L
    J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 12. Patents versus patients? Antiretroviral therapy in India.
    Havlir DV; Hammer SM
    N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
    [No Abstract]   [Full Text] [Related]  

  • 13. Sublicense or supply agreement? Supreme Court of Canada interpretation benefits generic pharmaceutical industry.
    Burshtein S
    Food Drug Law J; 1999; 54(1):73-91. PubMed ID: 11758562
    [No Abstract]   [Full Text] [Related]  

  • 14. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 15. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 16. India's new patent laws may still hurt generic drug supplies.
    Chatterjee P
    Lancet; 2005 Apr 16-22; 365(9468):1378. PubMed ID: 15841559
    [No Abstract]   [Full Text] [Related]  

  • 17. European Commission targets drug firms over illegal patent protection.
    Watson R
    BMJ; 2010 Jan; 340():c268. PubMed ID: 20080819
    [No Abstract]   [Full Text] [Related]  

  • 18. Indian pharma enters the global arena.
    Singh S
    Cell; 2007 Mar; 128(5):811-4. PubMed ID: 17350563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brazil and India clash with EU over seizure of generic drugs.
    Zarocostas J
    BMJ; 2009 Feb; 338():b558. PubMed ID: 19208720
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposed EU-India free trade agreement could impede manufacture of generic HIV drugs.
    Chu SK
    HIV AIDS Policy Law Rev; 2011 Apr; 15(2):22-3. PubMed ID: 21688702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.